Rankings
▼
Calendar
SCLX Q2 2024 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$73M
Q2 2024 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$16M
+30.1% YoY
Gross Profit
$12M
73.2% margin
Operating Income
-$16M
-95.4% margin
Net Income
-$38M
-229.6% margin
EPS (Diluted)
$-10.94
QoQ Revenue Growth
+50.4%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$105M
Total Liabilities
$319M
Stockholders' Equity
-$215M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$13M
+30.1%
Gross Profit
$12M
$8M
+42.5%
Operating Income
-$16M
-$23M
+31.5%
Net Income
-$38M
-$27M
-41.0%
← FY 2024
All Quarters
Q3 2024 →